Timing of Introduction of Complementary Foods - United States, 2016-2018

Insights

Many infants receive complementary foods before 4 months of age, earlier than recommended by the American Academy of Pediatrics (AAP). This early introduction may impact infant development and health outcomes.

Area of Science:

  • Pediatrics
  • Public Health
  • Nutrition

Background:

  • The American Academy of Pediatrics (AAP) recommends introducing complementary foods around 6 months of age.
  • Introducing foods before 4 months may be too early due to infant immaturity and can hinder exclusive breastfeeding.
  • Early introduction is potentially linked to increased risk of overweight and obesity.

Purpose of the Study:

  • To analyze the timing of complementary feeding introduction in infants.
  • To determine the prevalence of early introduction of complementary foods before 4 months of age.
  • To provide state-level estimates on early complementary feeding practices.

Main Methods:

  • Analysis of 2016-2018 data from the National Survey of Children's Health (NSCH).
  • Included data from 23,927 children aged 1-5 years.
  • Examined national and geographic variations in early introduction prevalence.

Main Results:

  • Nationally, 31.9% of infants were introduced to complementary foods before 4 months of age.
  • Prevalence varied significantly by geographic region, sociodemographic factors, and infant feeding characteristics.
  • These findings indicate widespread early introduction of complementary foods.

Conclusions:

  • A substantial proportion of infants are introduced to complementary foods before developmental readiness.
  • Healthcare providers and influencers should address infant feeding practices to reduce early introduction.
  • Further efforts are needed to align feeding practices with AAP recommendations.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
116
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
121
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
503
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
93
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
141
Dietary Connections01:23

Dietary Connections

In biological systems, most metabolic pathways are interconnected. The cellular respiration processes that convert glucose to ATP—such as glycolysis, pyruvate oxidation, and the citric acid cycle—tie into those that break down other organic compounds. As a result, various foods—from apples to cheese to guacamole—end up as ATP. In addition to carbohydrates, food also contains proteins and lipids—such as cholesterol and fats. All of these organic compounds are used...
60.6K